- inogenous (NASDAQ:INGN) on Monday announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2024.
- The company estimates that preliminary and unaudited total revenue in the fourth quarter of 2024 will be in the range of $79 million to $80 million, reflecting